Updated diabetes drug could reduce weekly injections

Professional Adviser
clock

Sufferers of type 2 diabetes may one day be able to control their condition and reduce the number of...

Sufferers of type 2 diabetes may one day be able to control their condition and reduce the number of injections they have to take each week from 14 to one, if Canadian research comes to fruition. Researchers at the University of Toronto discovered a re-formulated version of the drug Exenatide was better at controlling blood sugar levels than the current one, which needs to be injected twice a day. The preliminary study reported its findings as: "Exenatide once weekly resulted in significantly greater improvements of glycaemic control than Exenatide given twice a day, with no increased r...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on uncategorised

Brooks Macdonald becomes BAFTA wealth management partner

Brooks Macdonald becomes BAFTA wealth management partner

Partnership starts in 2026

Jen Frost
clock 08 December 2025 • 1 min read
As Reeves scrabbles for Budget funds, is she missing a Covid furlough trick?

As Reeves scrabbles for Budget funds, is she missing a Covid furlough trick?

Creativity key as chancellor faces tough tax and spending choices

Jen Frost
clock 21 November 2025 • 8 min read
Titan Wealth inks Harlequins partnership

Titan Wealth inks Harlequins partnership

Becomes wealth management and women’s partner

Jen Frost
clock 03 October 2025 • 2 min read